☰

Adam Bass

Affiliations: 
Dana-Farber Cancer Institute, Boston, MA, United States 
Google:
"Adam Bass"
Mean distance: (not calculated yet)
 
Tree Publications Grants Similar researchers PubMed Report error

Parents

Sign in to add mentor
Matthew Meyerson grad student Dana-Farber Cancer Institute

Children

Sign in to add trainee
Pranshu Sahgal post-doc 2020- Dana-Farber Cancer Institute
Nilay Sethi post-doc 2015-2020 Dana-Farber Cancer Institute (FlyTree)

Collaborators

Sign in to add collaborator
Morvarid Mohseni collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Schaefer A, Hodge RG, Zhang H, et al. (2023) RHOA drives the development of diffuse gastric cancer through IGF1R-PAK1-YAP1 signaling. Science Signaling. 16: eadg5289
Shah MA, Altorki N, Patel P, et al. (2023) Improving outcomes in patients with oesophageal cancer. Nature Reviews. Clinical Oncology. 20: 390-407
Keller RB, Mazor T, Sholl L, et al. (2023) Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal Cancer. Jco Precision Oncology. 7: e2200342
Chatila WK, Walch H, Hechtman JF, et al. (2023) Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers. Nature Communications. 14: 110
Peng K, Zhang F, Wang Y, et al. (2022) Development of combination strategies for Focal Adhesion Kinase inhibition in Diffuse Gastric Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Yang K, Cao Y, Gurjao C, et al. (2022) Clinical and Genomic Characterization of Interval Colorectal Cancer in Three Prospective Cohorts. Gastroenterology
Quante M, Wang TC, Bass AJ. (2022) Adenocarcinoma of the oesophagus: is it gastric cancer? Gut
Liu Y, Wu Z, Zhou J, et al. (2021) A predominant enhancer co-amplified with the SOX2 oncogene is necessary and sufficient for its expression in squamous cancer. Nature Communications. 12: 7139
He Y, Rivera J, Diossy M, et al. (2021) heterozygosity and replication stress drive esophageal cancer development in a mouse model. Proceedings of the National Academy of Sciences of the United States of America. 118
de Klerk LK, Patel AK, Derks S, et al. (2021) Phase II study of pembrolizumab in refractory esophageal cancer with correlates of response and survival. Journal For Immunotherapy of Cancer. 9
See more...